A critical discovery in cancer research is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital cancer suppressor protein is frequently inactivated in many kinds of cancer, resulting https://social40.com/story7534046/nanobodies-restore-tumor-suppressor-p53-a-potential-pathway-for-malignant-management